Document Type : Original Article
Authors
- Nasrin Ziamajidi 1, 2
- Mohammadjavad Hossein Tehrani 1
- Fariba Keramat 3, 4
- Roghayeh Abbasalipourkabir 1
- Zeinab Barartabar 1, 5
1 Department of Clinical Biochemistry, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
2 Molecular Medicine Research Center, Hamadan University of Medical Science, Hamadan, Iran
3 Brucellosis Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
4 Department of Infectious Diseases, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
5 Students Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran
Abstract
Background: The outbreak of the COVID-19 pandemic started in Wuhan, China, in December 2019 and spread rapidly around the world. Effective indicators to evaluate the severity and clinical progress of the disease need to be further investigated so that they can be used to reduce mortality. We sought to analyze the laboratory findings of some cases of coronavirus pneumonia in Iran.
Methods: This was a retrospective study of patients hospitalized with confirmed COVID-19 at Sina Hospital, affiliated with Hamadan University of Medical Sciences, between March 20, 2020, and June 21, 2021.
Results: The mean age of the 1400 patients was 57.2±16.18 years, of which 64.2% (896 patients) were over 50, 52.6% were men, and 85.95% were in the critical group. A total of 508 patients (78.0%) had hypoalbuminemia. Creatinine and blood urea nitrogen (BUN) levels increased in 16.2% and 12.5% of patients, respectively. Regarding liver enzymes, 27.7% of patients had an increase in the alanine aminotransferase (ALT) enzyme, and 46.3% also showed an increase in the aspartate aminotransferase (AST) enzyme.
Conclusion: A decrease in serum albumin, increased liver enzymes, and changes in kidney function tests were observed in patients with coronavirus. Moreover, it was found that these changes were associated with inflammatory markers. Screening and daily monitoring of patients lead to early identification of risk factors in patients.
Keywords
Main Subjects
- Kannan S, Shaik Syed Ali P, Sheeza A. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review. Eur Rev Med Pharmacol Sci. 2021;25(24):8019- 22. doi: 10.26355/eurrev_202112_27653.
- Fan Z, Chen L, Li J, Tian C, Zhang Y, Huang S, et al. Clinical Features of COVID-19-Related Liver Damage. 2020. Available from: https://ssrn.com/abstract=3546077.
- Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirusinfected pneumonia. N Engl J Med. 2020;382(13):1199-207. doi: 10.1056/NEJMoa2001316.
- Azarafza M, Azarafza M, Akgün H. Clustering method for spread pattern analysis of corona-virus (COVID-19) infection in Iran. medRxiv [Preprint]. May 28, 2020. Available from:https://www. medrxiv.org/content/10.1101/2020.05.22.20109942v2.full.
- Aminizadeh M, Saberinia A, Salahi S, Sarhadi M, Jangipour Afshar P, Sheikhbardsiri H. Quality of working life and organizational commitment of Iranian pre-hospital paramedic employees during the 2019 novel coronavirus outbreak. Int J Healthc Manag. 2022;15(1):36-44. doi: 10.1080/20479700.2020.1836734.
- Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MU, Khan K. Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. J Travel Med. 2020;27(2):taaa008. doi: 10.1093/jtm/taaa008.
- de la Rica R, Borges M, Aranda M, Del Castillo A, Socias A, Payeras A, et al. Low albumin levels are associated with poorer outcomes in a case series of COVID-19 patients in Spain: a retrospective cohort study. Microorganisms. 2020;8(8):1106. doi: 10.3390/microorganisms8081106.
- Wang P, Lu JA, Jin Y, Zhu M, Wang L, Chen S. Epidemiological characteristics of 1212 COVID-19 patients in Henan, China. medRxiv [Preprint]. February 25, 2020. Available from: https:// www.medrxiv.org/content/10.1101/2020.02.21.20026112v2.
- Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol. 2020;127:104364. doi: 10.1016/j.jcv.2020.104364.
- Huang Y, Yang R, Xu Y, Gong P. Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China. medRxiv [Preprint]. March 5, 2020. Available from: https://www. medrxiv.org/content/10.1101/2020.02.27.20029009v2.
- Parohan M, Yaghoubi S, Seraji A. Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies. Hepatol Res. 2020;50(8):924-35. doi: 10.1111/hepr.13510.
- Nogueira SÁ, de Oliveira SC, de Carvalho AF, Neves JM, da Silva L, da Silva Junior GB, et al. Renal changes and acute kidney injury in COVID-19: a systematic review. Rev Assoc Med Bras (1992). 2020;66Suppl 2(Suppl 2):112-7. doi: 10.1590/1806-9282.66.s2.112.
- Karthik L, Kumar G, Keswani T, Bhattacharyya A, Chandar SS, Bhaskara Rao KV. Protease inhibitors from marine actinobacteria as a potential source for antimalarial compound. PLoS One. 2014;9(3):e90972. doi: 10.1371/ journal.pone.0090972.
- Li Y, Hu Y, Yu J, Ma T. Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia. Lab Invest. 2020;100(6):794-800. doi: 10.1038/s41374-020-0431-6.
- Huang R, Zhu L, Xue L, Liu L, Yan X, Wang J, et al. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center study. PLoS Negl Trop Dis. 2020;14(5):e0008280. doi: 10.1371/journal. pntd.0008280.
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. doi: 10.1001/jama.2020.1585.
- Chen T, Dai Z, Mo P, Li X, Ma Z, Song S, et al. Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: a single-centered, retrospective study. J Gerontol A Biol Sci Med Sci. 2020;75(9):1788-95. doi: 10.1093/gerona/glaa089.
- Pinheiro I, Dejager L, Libert C. X-chromosome-located microRNAs in immunity: might they explain male/female differences? The X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females. Bioessays. 2011;33(11):791-802. doi: 10.1002/ bies.201100047.
- Meng Y, Wu P, Lu W, Liu K, Ma K, Huang L, et al. Sex specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: a retrospective study of 168 severe patients. PLoS Pathog. 2020;16(4):e1008520. doi: 10.1371/journal.ppat.1008520.
- Bernardi M, Angeli P, Claria J, Moreau R, Gines P, Jalan R, et al. Albumin in decompensated cirrhosis: new concepts and perspectives. Gut. 2020;69(6):1127-38. doi: 10.1136/ gutjnl-2019-318843.
- Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364-74. doi: 10.1007/s11427-020-1643-8.
- Li J, Li M, Zheng S, Li M, Zhang M, Sun M, et al. Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19. Biomark Med. 2020;14(10):827-37. doi: 10.2217/bmm-2020-0254.
- Kheir M, Saleem F, Wang C, Mann A, Chua J. Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19. PLoS One. 2021;16(3):e0248358. doi: 10.1371/journal.pone.0248358.
- Huang W, Li C, Wang Z, Wang H, Zhou N, Jiang J, et al. Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases. Sci China Life Sci. 2020;63(11):1678-87. doi: 10.1007/s11427-020-1733-4.
- Chen S, Zhang D, Zheng T, Yu Y, Jiang J. DVT incidence and risk factors in critically ill patients with COVID-19. J Thromb Thrombolysis. 2021;51(1):33-9. doi: 10.1007/s11239-020- 02181-w.
- Benedé-Ubieto R, Estévez-Vázquez O, Flores-Perojo V, Macías-Rodríguez RU, Ruiz-Margáin A, Martínez-Naves E, et al. Abnormal liver function test in patients infected with coronavirus (SARS-CoV-2): a retrospective single-center study from Spain. J Clin Med. 2021;10(5):1039. doi: 10.3390/ jcm10051039.
- Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052-9. doi: 10.1001/jama.2020.6775.
- Fan Z, Chen L, Li J, Tian C, Zhang Y, Huang S, et al. Clinical features of COVID-19-related liver damage. medRxiv [Preprint]. February 28, 2020. Available from: https://www. medrxiv.org/content/10.1101/2020.02.26.20026971v2.
- Saini RK, Saini N, Ram S, Soni SL, Suri V, Malhotra P, et al. COVID-19 associated variations in liver function parameters: a retrospective study. Postgrad Med J. 2022;98(1156):91-7. doi: 10.1136/postgradmedj-2020-138930.
- Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136(4):489-500. doi: 10.1182/blood.2020006520.
- Küçükceran K, Ayrancı MK, Girişgin AS, Koçak S, Dündar ZD. The role of the BUN/albumin ratio in predicting mortality in COVID-19 patients in the emergency department. Am J Emerg Med. 2021;48:33-7. doi: 10.1016/j.ajem.2021.03.090.
- Zhang G, Zhang J, Wang B, Zhu X, Wang Q, Qiu S. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Respir Res. 2020;21(1):74. doi: 10.1186/s12931-020-01338-8.
- Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-38. doi: 10.1016/j.kint.2020.03.005.
- Abolghasemi M, Samavarchi Tehrani S, Yousefi T, Karimian A, Mahmoodpoor A, Ghamari A, et al. MicroRNAs in breast cancer: roles, functions, and mechanism of actions. J Cell Physiol. 2020;235(6):5008-29. doi: 10.1002/jcp.29396.
- Cheng A, Hu L, Wang Y, Huang L, Zhao L, Zhang C, et al. Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients. Int J Antimicrob Agents. 2020;56(3):106110. doi: 10.1016/j.ijantimicag.2020.106110.
)